Recent share performance and business snapshot
Herbalife (HLF) has drawn investor attention after a mixed stretch for the stock, with the price flat over the past day but declining over the past week, month, and past 3 months.
Over the past week the stock fell about 9%, adding to a drop of roughly 30% over the past month and 26% over the past 3 months, even as the 1 year total return is positive.
At a last close of US$11.39 and a market value of about US$1.2b, the company sits in a segment of the market where sentiment can shift quickly as investors reassess risk and return trade offs.
See our latest analysis for Herbalife.
For Herbalife, recent momentum has clearly cooled, with the share price under pressure in the short term despite a 1 year total shareholder return of 53.09%. This suggests sentiment has swung more cautious even as longer term holders remain ahead.
If you are weighing Herbalife against other opportunities, it can help to see how different business models are being valued, especially outside consumer products, by scanning 21 top founder-led companies
With Herbalife trading at US$11.39 and some valuation models suggesting a discount, the key question is whether the recent share price weakness offers a genuine entry point or whether the market is already pricing in future growth.
Most Popular Narrative: 35% Undervalued
Herbalife's most followed narrative pegs fair value at $17.50 per share, well above the last close of $11.39. This frames the current discount as meaningful in that narrative.
The analysts have a consensus price target of $17.5 for Herbalife based on their expectations of its future earnings growth, profit margins and other risk factors.
However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $25.0, and the most bearish reporting a price target of just $9.0.
Want to see what sits behind that gap between bullish and cautious views? The narrative focuses on steady revenue progress, rising margins, and a future earnings multiple that is well below many consumer peers.
Result: Fair Value of $17.50 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, there are still clear risks in play, including tighter global scrutiny of multi level marketing models and persistent consumer skepticism toward processed supplements.
Find out about the key risks to this Herbalife narrative.
Next Steps
With sentiment clearly mixed, you do not need to wait to see how others react. Go straight to the data and weigh Herbalife's 3 key rewards and 3 important warning signs
Looking for more investment ideas?
If Herbalife is on your radar, do not stop there. Broader context across different types of stocks can sharpen your sense of risk, reward, and timing.
- Spot potential mispricings by comparing companies that screen as 47 high quality undervalued stocks so you can see where the market might be pricing in too much pessimism.
- Strengthen your focus on resilience by scanning 65 resilient stocks with low risk scores and concentrating on companies that score better on stability and downside protection.
- Aim ahead of the crowd by checking the screener containing 22 high quality undiscovered gems before other investors start paying closer attention.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com